Overcoming Barriers to Preventing and Treating P. aeruginosa Infections Using AAV Vectored Immunoprophylaxis
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10123162
Abstract: Pseudomonas aeruginosa is a bacterial pathogen of global concern and is responsible for 10–15% of nosocomial infections worldwide. This opportunistic bacterial pathogen is known to cause serious complications in immunocompromised patients and is notably the… read more here.
Keywords: aeruginosa infections; aav; preventing treating; barriers preventing ... See more keywords
Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58111533
Abstract: (1) Background: A biosimilar is a biologic medical product that has been approved by the United States Food and Federal Drug Administration (FDA) and is an almost identical copy of an original biologic product yet… read more here.
Keywords: oncology; oncology medication; identification barriers; barriers preventing ... See more keywords